Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor
Sina M. Coldewey(Jena University Hospital), Christoph Thiemermann(Queen Mary University of London), Anthony Cerami(Araim Pharmaceuticals (United States)), Mara Rogazzo(University of Turin), Michael Brines(Northwell Health), Julius Kieswich(Queen Mary University of London), Peter A. Hall(Population Health Research Institute), Nimesh S. A. Patel(William Harvey Research Institute), Massimo Collino(Neuroscience Institute), Michael Sheaff(Moorfields Eye Hospital NHS Foundation Trust), Amar Kapoor(Queen Mary University of London), Areeg I. Khan(Queen Mary University of London), Muhammed M. Yaqoob(Queen Mary University of London)
Cited by 76
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
The p53 pathway
|The Journal of Pathology|1999|1.3k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Mesenchymal Stromal Cells: Current Understanding and Clinical Status
|Stem Cells|2009|921